Statin therapy for primary prevention of cardiovascular disease
- PMID: 24276813
- DOI: 10.1001/jama.2013.281348
Statin therapy for primary prevention of cardiovascular disease
Abstract
Clinical question: Do statins reduce rates of cardiovascular events when used for primary prevention?
Bottom line: When used for primary prevention, statins are associated with lower rates of all-cause mortality, major vascular events, and revascularizations compared with placebo. Statin therapy is not associated with increased rates of life-threatening adverse effects such as cancer.
Comment in
-
Accumulating evidence for statins in primary prevention.JAMA. 2013 Dec 11;310(22):2405-6. doi: 10.1001/jama.2013.281355. JAMA. 2013. PMID: 24276744 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
